Tough transparency rules could harm innovation, researchers warn

04/18/2013 | MassDevice.com (Boston)

FDA premarket approval submissions are more often backed by patents produced by physician-owned startups than patents from nonphysician-owned startups, a Wolters Kluwer Health study finds. Researchers warn that enforcing burdensome financial disclosure rules could deter medtech firms from investing in physician-owned startups, which could hurt innovation.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA